News

Gabapentin, Valacyclovir Reduce Postherpetic Neuralgia in Herpes Zoster

Publish date: February 16, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY

Dr. Lapolla’s study was funded by the Foundation for Advances in Therapeutics and Prevention. The valacyclovir was provided by GlaxoSmithKline. Dr. Lapolla disclosed serving as a subinvestigator for NeurogesX and Inhibitex.

Pages

Recommended Reading

CCSVI and MS: Desperate Patients Find It Hard to Wait
MDedge Psychiatry
Statin Use Reduced Risk of Parkinson's in Cohort Study
MDedge Psychiatry
Norwegian Study Calculates Aneurysm Rupture Risk
MDedge Psychiatry
Stenting Works When Clot Treatments Fail in Large-Vessel Strokes
MDedge Psychiatry
Stents-on-Sticks Score for Acute Stroke
MDedge Psychiatry
Habit Reversal Training a Valid Drug Alternative for Tics
MDedge Psychiatry
CCSVI and MS: Desperate Patients Find It Hard to Wait
MDedge Psychiatry
Keep Open Mind About Alternative Autism Treatments
MDedge Psychiatry
New Imaging Agent Aids in Parkinson's Diagnosis
MDedge Psychiatry
New Epilepsy Treatments on the Horizon
MDedge Psychiatry